Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26, which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.

Following are the list of articles that have cited the articles published in Journal of Bioequivalence & Bioavailability.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Total published articles

40 57 60 61 19 6 27 57 60 62 46 60 47 71 27 21

Research, Review articles and Editorials

6 11 18 20 9 5 17 44 50 50 33 39 17 64 27 17

Research communications, Review communications, Editorial communications, Case reports and Commentary

34 46 42 41 10 1 10 13 10 12 13 23 30 7 0 4

Conference proceedings

0 0 0 0 21 11 72 40 62 44 89 112 250 144 97 0

Citations received as per Google Scholar, other indexing platforms and portals

254 315 394 412 405 380 363 384 615 378 376 169 96 170 0 0
Journal total citations count 4890
Journal impact factor 6.89
Journal 5 years impact factor 11.60
Journal cite score 14.43
Journal h-index 26
Important citations

Juárez SM, Morales JR, Urizar JT (2017) Caracterización farmacocinética de Citalopram en sujetos sanos empleando Cromatografía de Líquidos de Alta Resolución. JÓVENES EN LA CIENCIA :358-362.

Damodar R, Movva B (2014) Preparation and.

Tomar MS, Patni AK, Iyer S, Khuroo AH, Kumar S, Thudi NR, et al. (2011) Comparison of pharmacokinetics of citalopram in healthy Asian Indian and Mexican volunteers. Clin Res Regulatory Affairs 28:22-26.

Renati D, Vinay CV (2014) Role of Novel Hole Technology in Fast Dissolving Tablets. J Mol Pharm Organic Proc Res.

Damodar R, Movva B, Mallikarjun PN, Pasumarthy C, Kona N, Varsha PV (2014) Formulation and evaluation of fast dissolving tablets of diclofenac sodium by novel hole technology. J Mol Pharm Org Process Res 2:2-6.

Parthasarathi D, Gajendra C, Dattatreya A, Sree Venkatesh Y (2011) Analysis of pharmacokinetic & pharmacodynamic models in oral and transdermal dosage forms. J Bioequiv Availab 3:268-276.

Nishant T, Sathish Kumar D, Arun Kumar PM (2011) Role of pharmacokinetic studies in drug discovery. J Bioequiv Availab. 2011;3:263-267.

Dubey R, Das S, Kant K, Ghosh M. Validated liquid chromatography/tandem mass spectrometry method for determination and Pharmacokinetic study of metolazone in rat plasma.

Dubey R, Ghosh M, Sinha BN, Muthukrishnan V (2015) Simultaneous Determination and Pharmacokinetics of Metolazone, Losartan and Losartan Carboxylic Acid in Rat Plasma by HPLC–ESI–MS-MS. J Chromatogr Sci 53:1520-1527.

Walash MI, El‐Enany NM, Eid MI, Fathy ME (2014) Simultaneous determination of metolazone and losartan potassium in their binary mixtures using high‐performance liquid chromatography with fluorimetric detection: application to combined tablets and spiked human plasma. Luminescence 29:462-470.

Walash MI, El-Enany N, Eid MI, Fathy ME (2014) Stability–indicating spectrofluorimetric methods for the determination of metolazone and xipamide in their tablets. Application to content uniformity testing. J Fluorescence 24:363-376.

Walash MI, El-Enany N, Eid MI, Fathy ME (2013) Simultaneous determination of metolazone and spironolactone in raw materials, combined tablets and human urine by high performance liquid chromatography. Analytical Methods 5:5644-5656.

Jia Y, Zhang Y, Wang C, Wang Z, Liu Y, Wang J, et al. (2011) An improved LC‐MS/MS method for quantitative determination of metolazone in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr 25:1138-1143.

Zisaki A, Miskovic L, Hatzimanikatis V (2015) Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches. Curr Pharm Design 21:806-822.

Liu XI, Momper JD, Rakhmanina N, van den Anker JN, Green DJ, Burckart GJ, et al. (2019) Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir. J Clin Pharmacol.

Han WL, Shang JC, Yan B, Tan R, Huang WX, Zhong XN, et al. (2014) Pharmacokinetics of Single-and Multiple-Dose Emtricitabine in Healthy Male Chinese Volunteers. Pharmacol 93:166-171.

Barik SK, Mohanty K, Tripathy S, Gupta U, Bisht D, Jena S, et al. (2016) Human Immuno-Deficiency Virus Drug Resistance, Nuclesoide Reverse Transcriptase Inhibitors, Non-nuclesoide Reverse Transcriptase Inhibitors And Associated Drug Resistance Mutations In The Reverse Transcriptase Gene Of Human Immuno Deficiency Virus-1.

Parthasarathi D, Gajendra C, Dattatreya A, Sree Venkatesh Y (2011) Analysis of pharmacokinetic & pharmacodynamic models in oral and transdermal dosage forms. J Bioequiv Availab 3:268-276.

Nishant T, Sathish Kumar D, Arun Kumar PM (2011) Role of pharmacokinetic studies in drug discovery. J Bioequiv Availab 3:263-267.

Rigos G, Zonaras V, Cotou E, Henry M, Nikoloudaki X, Alexis M (2012) Dietary fish oil replacement does not alter quinolone uptake in gilthead seabream. Bulletin of the European Association of Fish Pathologists 32:94-102.